Evidence map›Paper›PMID 29966759›Full record

ArticleActa biomaterialia2018

Effect of age on biomaterial-mediated in situ bone tissue regeneration.

Mengqian Liu, Manando Nakasaki, Yu-Ru Vernon Shih, Shyni Varghese

Open access · greenAbstract read
In one paragraph

Article in Acta biomaterialia, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Development-based In Vivo Bioreactor Strategy for Challenging Senescent Bone Reconstruction.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Therapeutic application of hydrogels for bone-related diseases.Frontiers in bioengineering and biotechnology · 2022
    Review
  13. Article
  14. Article
  15. Hydrogels and Their Role in Bone Tissue Engineering: An Overview.Journal of pharmacy & bioallied sciences · 2021
    Review
  16. Review
  17. Applications of nanotechnology in 3D printed tissue engineering scaffolds.European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V · 2021
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Mengqian LiuDepartment of Mechanical Engineering and Materials Science, Duke University, Durham, NC 27710, United States.
Manando NakasakiDepartment of Bioengineering, University of California, San Diego, La Jolla, CA 92093, United States.
Yu-Ru Vernon ShihDepartment of Orthopaedic Surgery, Duke University, Durham, NC 27710, United States.
Shyni VargheseDepartment of Mechanical Engineering and Materials Science, Duke University, Durham, NC 27710, United States; Department of Orthopaedic Surgery, Duke University, Durham, NC 27710, United States; Department of Biomedical Engineering, Duke University, Durham, NC 27710, United States. Electronic address: shyni.varghese@duke.edu.
Duke University Hospital · USDuke University · USUniversity of California, San Diego · US

Funding

Adenosine A2B Receptor in Bone Health and OsteoporosisR01AR071552 · NIAMS · DUKE UNIVERSITY · PI VARGHESE, SHYNI · 2017 to 2021
$2.4M
Diversity Supplement -"Bioinspired Synthetic Grafts for Bone Regeneration"R01AR063184 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI VARGHESE, SHYNI · 2013 to 2017
$1.7M
NIAMS NIH HHS R01 AR063184NIAMS NIH HHS R01 AR071552
6 · The paper itself

Abstract

Emerging studies show the potential application of synthetic biomaterials that are intrinsically osteoconductive and osteoinductive as bone grafts to treat critical bone defects. Here, the biomaterial not only assists recruitment of endogenous cells, but also supports cellular activities relevant to bone tissue formation and function. While such biomaterial-mediated in situ tissue engineering is highly attractive, success of such an approach relies largely on the regenerative potential of the recruited cells, which is anticipated to vary with age. In this study, we investigated the effect of the age of the host on mineralized biomaterial-mediated bone tissue repair using critical-sized cranial defects as a model system. Mice of varying ages, 1-month-old (juvenile), 2-month-old (young-adult), 6-month-old (middle-aged), and 14-month-old (elderly), were used as recipients. Our results show that the bio-mineralized scaffolds support bone tissue formation by recruiting endogenous cells for all groups albeit with differences in an age-related manner. Analyses of bone tissue formation after 2 and 8 weeks post-treatment show low mineral deposition and reduced number of osteocalcin and tartrate-resistant acid phosphatase (TRAP)-expressing cells in elderly mice. STATEMENT OF SIGNIFICANCE: Tissue engineering strategies that promote tissue repair through recruitment of endogenous cells will have a significant impact in regenerative medicine. Previous studies from our group have shown that biomineralized materials containing calcium phosphate minerals can contribute to neo-bone tissue through recruitment and activation of endogenous cells. In this study, we investigated the effect of age of the recipient on biomaterial-mediated bone tissue repair. Our results show that the age of the recipient mouse had a significant impact on the quality and quantity of the engineered neo-bone tissues, in which delayed/compromised bone tissue formation was observed in older mice. These findings are in agreement with the clinical observations that age of patients is a key factor in bone repair.

Indexed as

AgingAnimalsBiocompatible MaterialsBiomarkersBone and BonesBone RegenerationFemaleMice, Inbred C57BLNeovascularization, PhysiologicOsteogenesisSkullBiocompatible MaterialsBiomarkersAge effectBone repairCranial defectEndogenous cellsIn situ tissue engineeringMineralized biomaterialOsteoinductive

Identifiers

PMID29966759
PMCPMC6286153
OpenAlexW2810718827

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.